News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,207 Results
Type
Article (43460)
Company Profile (270)
Press Release (697462)
Multimedia
Podcasts (91)
Webinars (23)
Section
Business (209061)
Career Advice (2124)
Deals (36042)
Drug Delivery (127)
Drug Development (82588)
Employer Resources (177)
FDA (16661)
Job Trends (15193)
News (353061)
Policy (33339)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2675)
Accelerated approval (42)
Adcomms (31)
Allergies (160)
Alliances (50546)
ALS (193)
Alzheimer's disease (1764)
Antibody-drug conjugate (ADC) (373)
Approvals (16977)
Artificial intelligence (600)
Autoimmune disease (225)
Automation (50)
Bankruptcy (365)
Best Places to Work (11777)
BIOSECURE Act (20)
Biosimilars (205)
Biotechnology (175)
Bladder cancer (177)
Brain cancer (64)
Breast cancer (694)
Cancer (5352)
Cardiovascular disease (445)
Career advice (1802)
Career pathing (42)
CAR-T (303)
CDC (54)
Celiac Disease (2)
Cell therapy (811)
Cervical cancer (41)
Clinical research (71082)
Collaboration (1914)
Company closure (4)
Compensation (1270)
Complete response letters (69)
COVID-19 (2758)
CRISPR (99)
C-suite (993)
Cystic fibrosis (148)
Data (7087)
Decentralized trials (3)
Denatured (30)
Depression (153)
Dermatology (57)
Diabetes (557)
Diagnostics (6958)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (300)
Drug pricing (200)
Drug shortages (29)
Duchenne muscular dystrophy (266)
Earnings (92886)
Editorial (61)
Employer branding (21)
Employer resources (155)
Events (121075)
Executive appointments (1047)
FDA (20095)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1628)
Gene editing (211)
Generative AI (52)
Gene therapy (665)
GLP-1 (1032)
Government (4792)
Grass and pollen (6)
Guidances (397)
Healthcare (19230)
HIV (75)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (272)
Immuno-oncology (82)
Indications (157)
Infectious disease (3074)
Inflammatory bowel disease (205)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (275)
Interviews (329)
IPO (16849)
IRA (50)
Job creations (3737)
Job search strategy (1506)
JPM (58)
Kidney cancer (18)
Labor market (93)
Layoffs (563)
Leadership (37)
Legal (8085)
Liver cancer (99)
Longevity (28)
Lung cancer (723)
Lymphoma (406)
Machine learning (52)
Management (61)
Manufacturing (929)
MASH (177)
Medical device (14099)
Medtech (14178)
Mergers & acquisitions (20358)
Metabolic disorders (1427)
mRNA (175)
Multiple sclerosis (173)
NASH (17)
Neurodegenerative disease (390)
Neuropsychiatric disorders (97)
Neuroscience (3166)
Neurotech (1)
NextGen: Class of 2026 (6631)
Non-profit (4634)
Now hiring (73)
Obesity (675)
Opinion (284)
Ovarian cancer (185)
Pain (228)
Pancreatic cancer (257)
Parkinson's disease (347)
Partnered (34)
Patents (555)
Patient recruitment (591)
Peanut (60)
People (60551)
Pharmaceutical (62)
Pharmacy benefit managers (32)
Phase 1 (22143)
Phase 2 (31275)
Phase 3 (23299)
Pipeline (7129)
Policy (306)
Postmarket research (2651)
Preclinical (9446)
Press Release (64)
Prostate cancer (278)
Psychedelics (51)
Radiopharmaceuticals (303)
Rare diseases (999)
Real estate (6107)
Recruiting (71)
Regulatory (25386)
Reports (54)
Research institute (2474)
Resumes & cover letters (362)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (165)
Series A (268)
Series B (200)
Service/supplier (11)
Sickle cell disease (107)
Special edition (22)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3683)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (87)
The Weekly (59)
Vaccines (1072)
Venture capital (100)
Weight loss (431)
Women's health (111)
Worklife (20)
Date
Last 7 days (644)
Last 30 days (2445)
Last 365 days (30174)
2026 (8060)
2025 (30472)
2024 (35526)
2023 (40486)
2022 (51677)
2021 (56301)
2020 (54766)
2019 (47457)
2018 (35742)
2017 (32833)
2016 (32300)
2015 (38445)
2014 (32129)
2013 (27107)
2012 (29399)
2011 (30035)
2010 (28126)
Location
Africa (784)
Alabama (90)
Alaska (7)
Arizona (335)
Arkansas (13)
Asia (41021)
Australia (6758)
California (12306)
Canada (3515)
China (1251)
Colorado (524)
Connecticut (524)
Delaware (367)
Europe (89781)
Florida (1851)
Georgia (394)
Hawaii (3)
Idaho (62)
Illinois (962)
India (83)
Indiana (561)
Iowa (22)
Japan (492)
Kansas (130)
Kentucky (44)
Louisiana (39)
Maine (85)
Maryland (1493)
Massachusetts (8814)
Michigan (355)
Minnesota (680)
Mississippi (6)
Missouri (147)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (83)
New Jersey (3277)
New Mexico (28)
New York (3250)
North Carolina (1592)
North Dakota (8)
Northern California (6071)
Ohio (369)
Oklahoma (23)
Oregon (41)
Pennsylvania (2486)
Puerto Rico (26)
Rhode Island (50)
South America (1159)
South Carolina (76)
South Dakota (1)
Southern California (4845)
Tennessee (199)
Texas (1943)
United States (43685)
Utah (370)
Vermont (1)
Virginia (292)
Washington D.C. (82)
Washington State (983)
West Virginia (4)
Wisconsin (124)
Wyoming (2)
741,207 Results for "artemis international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KalVista Pharmaceuticals Announces Inclusion of EKTERLY® (sebetralstat) as a First-Line Therapy for Adolescents 12 and Older in International Pediatric HAE Guideline
February 18, 2026
·
8 min read
Press Releases
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)
March 18, 2026
·
7 min read
Press Releases
Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD
March 4, 2025
·
10 min read
Press Releases
Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
March 3, 2026
·
3 min read
Job Trends
Talent Acquisition Leaders Reframe Recruiting, Focus On Internal Mobility
Talent acquisition leaders at leading pharma and biotech organizations are leveraging technologies
,
including automation
,
to develop internal talent marketplaces and systems that support upskilling and reskilling their workforce.
BioSpace
spoke to leaders at Pfizer and Bayer about their evolving approach to resourcing.
September 24, 2025
·
3 min read
·
Chantal Dresner
Press Releases
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
April 1, 2026
·
3 min read
Drug Development
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
Omeros Corporation (Nasdaq: OMER) today provided an update regarding the interim analysis outcome in ARTEMIS-IGAN, the Company’s Phase 3 trial evaluating narsoplimab for the treatment of immunoglobulin A (IgA) nephropathy.
October 16, 2023
·
5 min read
Press Releases
Notice to Annual General Meeting in BioInvent International AB
March 24, 2026
·
21 min read
Press Releases
Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
January 5, 2026
·
5 min read
Press Releases
Persephone Biosciences Announces First Subject Enrolled in ARTEMIS Clinical Trial of New Infant Synbiotic
January 23, 2025
·
4 min read
Previous
2 of 74,121
Next
